Speaker: Jeremy Walsh, Chief AI Officer at U.S. Food and Drug Administration
Date: December 3, 2025 at 1:00PM - 2:00PM
Talk Title: Transforming the FDA into a Real Time Regulatory Environment
Speaker: Wanda Barfield, MD, MPH, FAAP, RADM USPHS, Director, Division of Reproductive Health at Centers for Disease Control (CDC)
Date: November 10, 2022 at 4:00PM - 5:00PM
Talk Title: Maternal and Infant Health Data Equity and Modernization: Are We There Yet?
Speaker: Christopher Longhurst, MD, Chief Medical Officer and Chief Digital Officer at UC San Diego Health
Date: April 4, 2022 at 4:00PM - 5:00PM
Talk Topic: Interoperable Pandemic IT Innovations in California at Population Scale.
Speaker: Aaron Kesselheim, MD, JD, MPH, Professor of Medicine at Harvard Medical School
Date: September 23, 2021 at 4:00PM - 5:30PM
Dr. Aaron Kesselheim, former member of the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee who resigned over the agency’s approval of Aducanumab, will speak about the FDA’s accelerated approval pathway, how it is implemented, and how it was applied in the controversial Aducanumab case – which he dubbed the “worst drug approval decision in recent U.S. history.” Dr. Kesselheim will also give suggestions for the future. This should be a fascinating talk with wide implications for all future accelerated drug approval pathways.
Speaker: Ben Reis, PhD, Assistant Professor of Pediatrics, Computational Health Informatics Program at Boston Children's Hospital
Date: July 22, 2021 at 3:00PM - 4:00PM
The Delta (B.1.617.2) variant of the SARS-CoV-2 virus has rapidly emerged as the dominant strain spreading in many countries worldwide. Dr. Ben Reis led a discussion reviewing the latest findings on the Delta variant, with a focus on the effectiveness of approved COVID-19 vaccines against this emerging viral strain. Dr. Reis reviewed the evidence available from scientific publications, preliminary studies and public health reports, in the context of the inherent challenges involved in real-world vaccination effectiveness studies.
